RYTM : Insider Transactions for Rhythm Pharmaceuticals, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Rhythm Pharmaceuticals, Inc. (RYTM)

$39.14

0.64 (1.66%) as of 4:30 Fri 5/10

Download

Exchange:

N/A

Security Type:

Common

Shares Out:

70,932,000

Market Cap:

2.78(B)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$15.81 - $52.44

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company focused on changing the paradigm for the treatment of rare genetic diseases of obesity, which are characterized by early-onset, severe obesity and hyperphagia, a pathological and insatiable hunger. Co. is developing IMCIVREE™ (setmelanotide) as a medicine strategy for a subset of individuals who have severe obesity due to genetic variants that impair the melanocortin-4 receptor pathway, a pathway in the brain that is responsible for regulating hunger, caloric intake and energy expenditure, which consequently affect body weight.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	171,413	357,434	386,701	425,485
Total Sell Value	$6,861,691	$14,691,044	$15,456,647	$16,295,598
Total People Sold	7	7	7	8
Total Sell Transactions	20	34	41	60
End Date	2024-02-11	2023-11-10	2023-05-12	2022-05-12

Adjust Filter Settings

Records found: 251

Page 8 of 11

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Director

– • –

2019-12-11

4

AS

$25.14

$341,904

I/I

(13,600)

2,397,259

-

Director

– • –

2019-12-10

4

AS

$25.36

$1,061,037

I/I

(41,839)

2,410,859

-

Director

– • –

2019-12-09

4

AS

$25.04

$555,763

I/I

(22,195)

2,452,698

-

Director

– • –

2019-12-03

4

AS

$22.33

$374,630

I/I

(16,777)

2,474,893

-

Director

– • –

2019-12-02

4

AS

$22.03

$558,813

I/I

(25,366)

2,491,670

-

Director

– • –

2019-11-25

4

AS

$23.04

$2,810,839

I/I

(121,343)

2,644,580

-

Director

– • –

2019-11-22

4

AS

$21.78

$2,236,718

I/I

(102,682)

2,765,923

-

Director

– • –

2019-11-21

4

AS

$20.50

$1,334,141

I/I

(64,923)

2,868,605

-

Director

– • –

2019-11-20

4

AS

$22.02

$3,112,857

I/I

(141,365)

2,933,528

-

Kolchinsky Peter

10% Owner

– – •

2019-10-16

3

IO

$0.00

$0

I/I

0

5,422,312

-

Chief Commercial Officer

• – –

2019-08-12

4

OE

$6.88

$99,994

D/D

14,534

29,068

-

Gottesdiener Keith Michael

CEO and President

• • –

2019-07-16

4

OE

$4.59

$34,425

D/D

7,500

513,842

-

Chief Financial Officer

• – –

2019-07-11

4

OE

$6.88

$68,800

D/D

10,000

16,000

-

Van Der Ploeg Leonardus H.t.

Chief Scientific Officer

• – –

2019-05-31

4

S

$25.10

$125,500

D/D

(5,000)

42,339

-

Van Der Ploeg Leonardus H.t.

Chief Scientific Officer

• – –

2019-05-31

4

OE

$4.59

$22,950

D/D

5,000

47,339

-

Van Der Ploeg Leonardus H.t.

Chief Scientific Officer

• – –

2019-05-30

4

S

$25.31

$126,550

D/D

(5,000)

42,339

-

Van Der Ploeg Leonardus H.t.

Chief Scientific Officer

• – –

2019-05-30

4

OE

$4.59

$22,950

D/D

5,000

47,339

-

Van Der Ploeg Leonardus H.t.

Chief Scientific Officer

• – –

2019-05-29

4

S

$25.51

$127,550

D/D

(5,000)

42,339

-

Van Der Ploeg Leonardus H.t.

Chief Scientific Officer

• – –

2019-05-29

4

OE

$4.59

$22,950

D/D

5,000

47,339

-

Van Der Ploeg Leonardus H.t.

Chief Scientific Officer

• – –

2019-05-28

4

S

$25.38

$253,800

D/D

(10,000)

42,339

-

Van Der Ploeg Leonardus H.t.

Chief Scientific Officer

• – –

2019-05-28

4

OE

$4.59

$46,117

D/D

10,000

52,339

-

Gottesdiener Keith Michael

CEO & President

• • –

2019-03-18

4

AS

$30.27

$70,499

D/D

(2,329)

506,342

-

Gottesdiener Keith Michael

CEO & President

• • –

2019-03-15

4

AS

$30.04

$239,148

D/D

(7,961)

508,671

-

Gottesdiener Keith Michael

CEO & President

• • –

2019-03-14

4

AS

$30.05

$45,255

D/D

(1,506)

516,632

-

Gottesdiener Keith Michael

CEO & President

• • –

2019-03-13

4

AS

$30.06

$233,927

D/D

(7,782)

518,138

-

251 Records found	1 2 3 4 5 6 7 8 9 Next	Page 8 of 11

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.